Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jun Zhou has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Chaofu Wang

    Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    8 shared publications
  • Luting Zhou

    Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

    6 shared publications
  • Qin Shen

    Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine

    4 shared publications
  • Wenjing Zhang

    Shanghai Jiaotong University School of Medicine

    4 shared publications
  • Xiaoqun Yang

    Department of Pathology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China

    4 shared publications
  • Dandan Zhang

    Department of Pathology, The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, China; Basic Medicine College of Zhengzhou UniversityZhengzhou, China

    3 shared publications

Latest Publications

  • Elastic Staining Features in Pulmonary Non-Mucinous Adenocarcinoma and Associated In Situ Lesions: Diagnostic Implications

    by Jun Zhou, Anran Wang, Xue Wang, Wenjing Zhang, Qin Shen, Xiao-Jun Zhou

    Elastic staining may aid in the diagnosis of pulmonary non-mucinous adenocarcinoma and its in situ lesions. This study evaluated elastic staining patterns and their diagnostic utility in a multi-cohort series. Elastic staining was performed in 120 lesions, including a principal cohort ( n = 60), an internal validation cohort ( n = 30), an external validation cohort ( n = 30), and an interobserver agreement cohort ( n = 40). Staining patterns were analyzed and their impact on diagnostic accuracy was assessed. Four elastic staining patterns were identified: a point-and-linear pattern, an intensified point-and-linear pattern, a disorderly thickened and recoiled pattern with continuous and discontinuous variants, and a decreased or disappeared pattern. All adenocarcinoma in situ lesions and the in situ components of minimally invasive adenocarcinoma and invasive adenocarcinoma demonstrated the continuous disorderly thickened and recoiled pattern. The decreased or disappeared pattern was observed in the majority of invasive adenocarcinomas and in all invasive components of minimally invasive adenocarcinoma, whereas a subset of invasive adenocarcinomas exhibited the discontinuous variant associated with extensive carcinomatous collapse. Non-neoplastic lesions displayed a point-and-linear pattern, with an intensified point-and-linear pattern observed in regions of iatrogenic or mechanical collapse. No significant differences were identified between validation cohorts ( P > 0.05). Diagnostic accuracy and histologic identification improved with the use of elastic staining among both trainee and general pathologists, and interobserver agreement was high (Kappa = 0.945). Overall, elastic staining represents a useful adjunct for improving diagnostic accuracy and histologic classification of pulmonary non-mucinous adenocarcinoma and its in situ lesions.

  • Squamous papilloma of the external ear in Southwest China: A large case series highlighting predominant HPV subtypes, pathologic features, and unique epidemiologic factors.

    by Jun Zhou, Tianming Yang, Wenjuan Cheng, Youquan Zhao

    Squamous papilloma (SP) of the external ear is a rare benign neoplasm, with limited research on its associated human papillomavirus (HPV) infections and pathologic features. This study aims to provide a comprehensive analysis of the largest case series of external ear SP from Southwest China. We retrospectively collected 88 cases diagnosed with SP in the external ear canal, of which 85 (97%) were located in the external auditory canal and 3 (3%) on the auricle. We investigated the clinical, pathological, and HPV-typing characteristics using Polymerase chain reaction (PCR) and reverse dot blot (RDB) hybridization. Our series included 74 males and 14 females, with a median age of 62.5 years (range: 5-91 years). The predominant HPV type was HPV-6 (59/62, 95.2%), followed by high-risk types HPV-16 (4/62, 6.5%), HPV-52 (2/62, 3.2%), and HPV-58 (1/62, 1.6%). Histologically, all cases demonstrated typical features of SP, including koilocytes, hyperkeratosis, and basal/parabasal hyperplasia. Additionally, co-infection with multiple HPV types was observed in four cases. Notably, high-risk HPV types were detected in seven cases, all of which were completely excised with no recurrence during follow-up. This study suggests regional variations in HPV-subtype distribution and highlights potential environmental factors contributing to the prevalence of SP in Southwest China.

    • 15 January 2022
      • Vol. 14  (1) , 693-694

    Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

    by Jun Zhou, Wenjing Zhang, Yanping Zhang, Saifang Zheng, Luting Zhou, Xiaoqun Yang, Chaofu Wang

    [This corrects the article on p. 6751 in vol. 12, PMID: 33194070.].

  • Anastomosing Hemangioma Incidentally Found in Kidney or Adrenal Gland: Study of 10 Cases and Review of Literature

    by Jun Zhou, Xiaoqun Yang, Luting Zhou, Ming Zhao, Chaofu Wang

    Purpose: To describe and report a series of renal and adrenal anastomosing hemangioma (AH) and to investigate its distinctive clinicopathologic features and review its clinical data available in the literature. Materials and Methods: Clinical data of 10 AHs were retrospectively studied. Imaging and histologic features were re-evaluated and summarized. Immunostaining markers performed include CD31, CD34, ERG, Fil-1, D2-40, AE1/AE3, SMA, CD10, HHV8, S100, Ki-67. A follow-up of all cases was performed. Other AHs published in PubMed and Web of Science were reviewed. Results: All of 10 AHs were found incidentally in 5 female and 5 male patients (median age, 48.5 years; mean, 51.7 years) and involved unilateral kidney (n=7) and adrenal glands (n=3) respectively. All lesions were well-defined in imaging and histologic examination. AHs were morphologically characterized by prominent anastomosing vascular channels without evidence of infiltration to surrounding normal tissues and significant cellular atypia. CD31, CD34, ERG were positive and Ki-67 showed typically low positivity (< 3%). All Patients underwent a mass resection and none of them had evidence of recurrence. Together with other cases published, the AHs showed distinctive clinicopathologic features with an excellent prognosis. Conclusion: Renal or adrenal AH is a very rare vascular tumor. They have distinctive histologic features and a favorable prognosis. It is frequently mimicking well-differentiated angiosarcomas which easily results in unnecessary overtreatment in clinical practice.


  • Juxtaglomerular cell tumor: Clinicopathologic evaluation in a large series emphasizing its broad histologic spectrum

    by Jun Zhou, Saifang Zheng, Yanping Zhang, Yijian Yu, Luting Zhou, Wenjing Zhang, Chaofu Wang, Qin Shen, Xiaoqun Yang

    The juxtaglomerular cell tumor (JCT) is a rare renal tumor. We re‐evaluated the clinicopathologic features of 21 JCTs to summarize their variable morphologies. Immunohistochemical, fluorescent in situ hybridization and periodic acid–Schiff stains were routinely performed, and four JCT cases were detected via transmission electron microscopy. The 21 JCTs involved five males and 16 females, ranging in age from 19 years to 69 years (mean, 36.9 years; median, 34 years). The tumors were composed of large, small, or spindle cells with a round, oval or polygonal shape, arranged in various growth patterns. Both necrosis (1/21) and mitosis (2/21, with 1/50HFP, 8/50HFP) was rarely appreciated. All cases were immunoreactive for renin and CD34 (21/21), and few were positive for α‐SMA (13/21;11/21, focally; 2/21, diffusely,), CD117 (9/21, focally) and synaptophysin (3/21, focally). Ultrastructurally, all four cases exhibited secretory granules in varying sizes in the cytoplasm, two of which exhibited cellular junctions. Almost all cases (20/21) had a favorable prognosis, but one succumbed due to bone and hepatic metastases, which corresponds to malignant JCT. Our study demonstrates that JCTs may have atypical clinical presentations and variable histologic appearances. A familiarity with these features may contribute to a correct diagnosis.


  • Open Access

    The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour

    by Luting Zhou, Anran Wang, Guoli Yu, Jun Zhou, Haimin Xu, Chaofu Wang

    The expression of TFE3 (transcription factor E3) in solitary fibrous tumours (SFTs) and their histologic mimickers was investigated, and the diagnostic value and clinical significance of TFE3 nuclear expression in SFTs were explored. Immunohistochemical analysis for TFE3 was performed on 50 cases of SFTs that were surgically resected. The controls were sample tissues from malignant peripheral nerve sheath tumour, synovial sarcoma, dedifferentiated liposarcoma, spindle cell lipoma, and dermatofibrosarcoma protuberans. The survival of patients with TFE3-positive and TFE3-negative expressions was assessed through the Kaplan-Meier analysis. In 44 of 50 (88%) SFTs, nuclear immunoreactivity for TFE3 was detected. The TFE3 expression was negative in all samples of synovial sarcoma, malignant peripheral nerve sheath tumour, dermatofibrosarcoma protuberans, and spindle cell lipoma and weakly positive in 2 of 10 cases of dedifferentiated liposarcoma. Fluorescence in situ hybridization (FISH) confirmed that the expression of the TFE3 protein is not caused by gene translocation. There was no statistical significance between the association of the TFE3 expression and SFT patient prognosis. Therefore, TFE3 is capable of enhancing the differential diagnosis of SFTs and their histologic mimickers and can be potentially used as a diagnostic marker. The findings also offer valuable insights into SFT diagnosis, aetiology, and associated molecular mechanisms.


    • 1 January 2020
      • Vol. 12  (10) , 6751-6762

    Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls

    by Jun Zhou, Wenjing Zhang, Yanping Zhang, Saifang Zheng, Luting Zhou, Xiaoqun Yang, Chaofu Wang

    Clinicopathologic data of 16 cases of DLBCL, NOS after CD19-targeted CAR T-cell therapy were retrospectively reviewed. Statistical analyses were performed to investigate the diagnostic agreement and indicate the relationship of the given types or their alterations (Group I versus Group II) to the prognosis. A total of 5 distinct histologic patterns were summarized. The CAR T cells were somewhat atypical, most of which were CD8 positive in the most cases (86.7%, 13/15), with a relatively high Ki-67 (60-90%). The rearrangement of BCR was demonstrated in all cases. The diagnostic test showed that the diagnostic accuracy in cases of types III (7%) and V (7%) was typically low; the diagnostic agreement in cases of type IV (for B, T, or nonlymphoma) and V (for T, or nonlymphoma) was consistently unsatisfactory. The rates of complete response (CR), partial response (PR), and progressive disease (PD) were 18.8% (3/16), 31.3% (5/16), 50% (8/16), respectively. In the follow-up, 25% (4/16) of cases experienced a recurrence and 31.3% (5/16) had died, of which 3 cases succumbed to the side effects. Group II had better disease-free survival (DFS, P=0.009). This study first described the pathologic features of DLBCL after CD19-targeted CAR T-cell therapy. Familiarity with these histologic features and combinations of medical history and genetic analyses facilitate avoiding misdiagnoses. Multiple biopsies are potentially helpful to estimate the treatment effects or prognosis, and stable alterations to any type of III to V, but not a single given one, may indicate a good prognosis.


  • Open Access

    Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva

    by Luting Zhou, Xiang Yong, Jun Zhou, Jiankun Xu, Chaofu Wang

    Aims. NUT midline carcinoma (NMC) is a rare, poorly differentiated carcinoma defined by the presence of NUT gene rearrangement. In order to better understand the diagnostic and clinicopathologic features of this disease as they pertain to clinical practice, we have herein compiled findings pertaining to 5 cases of NMC at our institution. Methods. Clinicopathological findings from 5 NMC cases were retrospectively reviewed, with histologic findings being reassessed and summarized accordingly. Tumor samples in the present study had been stained for markers including NUT, P63, P40, TTF‐1, keratin, CK7, Syn, CD56, CgA, CD34, CD117, EGFR, and Ki‐67. All cases were subjected to both fluorescence in situ hybridization (FISH) and followed up. Results. Of these 5 NMC cases, 2 were males and 3 were females, with ages ranging from 26 to 69 years. A total of 2 cases localized to the lung, 1 to the larynx, 1 to the maxillary gingiva, and 1 to the orbital cavity. Upon microscopic assessment, these tumors appeared as clusters of small rounded cells with interstitial neutrophil infiltration. Squamous epithelial differentiation varied between samples. NUT staining revealed strong diffuse nuclear staining in tumor cells, and FISH confirmed the presence of NUT gene translocation in these samples. Conclusions. NMC is a form of highly invasive cancer that can manifest in a number of tissues including the gingiva. NMC tumors have a fairly well‐defined pathological morphology, and both immunohistochemistry and FISH are valuable for NMC diagnosis.


  • Open Access

    Combined Immunohistochemistry for the “Three 7” Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution

    by Jun Zhou, Xiaoqun Yang, Luting Zhou, Peipei Zhang, Chaofu Wang

    Background. There is a morphological overlap among renal epithelial tumors, particularly chromophobe renal cell carcinoma (CHRCC), clear cell renal cell carcinoma (CCRCC), renal oncocytoma (RO), and papillary renal cell carcinoma (PRCC). Discriminating between these tumors is important but sometimes challenging. This study is aimed at evaluating the clinical usefulness of the combined immunochemistry for the “three 7” markers (CK7, CD117, and Claudin-7) to distinguish chromophobe renal cell carcinoma from these mimics.Methods. Immunochemical staining for CK7, CD117, and Claudin-7 was performed in 68 CHRCCs, 199 CCRCCs, 32 ROs, and 30 PRCCs. Fluorescence in situ hybridization (FISH) was performed in some cases to exclude CCRCC and PRCC. The sensitivity (SE) and specificity (SP) for CHRCC as well as the immunoreactivity of each marker and their combinations were statistically evaluated.Results. High positive rates for CK7 (94%), CD117 (87%), Claudin-7 (94%), and their combinations (CK7+CD117, 79%; CK7+Claudin-7, 88%; CD117+Claudin-7, 82%; CK7+CD117+Claudin-7, 76%) were observed in CHRCC compared to those in CCRCC, RO, and PRCC, with increasingly higher SP when combinations of the “three 7” markers were applied (CK7, 0.80; CD117, 0.82; Claudin-7, 0.78; CK7+CD117, 0.95; CK7+Claudin-7, 0.97; CD117+Claudin-7, 0.97; CK7+CD117+Claudin-7, 1).Conclusion. CK7, CD117, and Claudin-7 are frequently expressed in CHRCC with high specificity. We recommend the routine use of these 3 markers as a routine panel when making a differential diagnosis of CHRCC and excluding other mimics.